Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi-Aventis S.A. ADR (NQ: SNY ) 55.05 -0.17 (-0.31%) Streaming Delayed Price Updated: 10:06 AM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sanofi-Aventis S.A. ADR < Previous 1 2 ... 23 24 25 26 27 28 29 30 Next > The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case December 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir... Via Benzinga Topics Intellectual Property Exposures COVID-19 Intellectual Property Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition December 01, 2021 Sanofi SA (NASDAQ: SNY) has agreed to buy Austrian group Origimm Biotechnology, a move that will add a potential first-in-class vaccine candidate to treat acne... Via Benzinga Baidu Licenses Its Algorithm To Sanofi For mRNA Vaccine, Therapy Development November 22, 2021 Baidu Inc (NASDAQ: BIDU) has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA (NASDAQ: SNY) for use in designing vaccine and... Via Benzinga The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial November 19, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Connect Biopharma Atopic Dermatitis Treatment Aces Mid-stage Study But Lack... Via Benzinga Earnings Scheduled For October 28, 2021 October 28, 2021 Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •... Via Benzinga Increased Prevalence of Atopic Dermatitis Fueling Impressive Growth for Atopic Dermatitis Drugs November 30, 2021 Palm Beach, FL –November 30, 2021 – FinancialNewsMedia.com News Commentary – Atopic dermatitis is a chronic inflammatory skin condition characterized by red, itchy, swollen, and broken skin. White... Via FinancialNewsMedia Pfizer Seeks Covid Boosters For All; But How Long Is The Opportunity? November 10, 2021 Both vaccine stocks popped after Pfizer asked for booster authorization in all adults. Via Investor's Business Daily Sanofi (SNY) Q3 2021 Earnings Call Transcript October 29, 2021 SNY earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs October 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc... Via Benzinga Sanofi Raises FY21 Earnings Outlook As Dupixent, Vaccines Boost Q3 Performance October 28, 2021 Sanofi SA's (NASDAQ: SNY) Q3 sales grew 10.1% Y/Y to €10.4 billion due to solid growth from Dupixent, Vaccines, and Consumer Healthcare. EPS for the... Via Benzinga The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs October 22, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Athira Names Chief Operating Officer Mark Litton As Next CEO as Leen Kawas... Via Benzinga The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More October 24, 2021 Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO October 21, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine... Via Benzinga Exposures Product Safety Bitcoin Futures Arrive October 19, 2021 Today you can finally hold Bitcoins via an exchange-traded fund. Via Talk Markets Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage October 18, 2021 Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral... Via Talk Markets The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs October 18, 2021 Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news.... Via Benzinga Exposures Product Safety Regeneron Could Have a Big Catalyst Coming in 2022 October 09, 2021 Cancer drug Libtayo could receive FDA approval for its fourth indication in January. Via The Motley Fool Exposures Product Safety Will Chart Analysts Notice Bad Omen on Sanofi's Chart October 08, 2021 If history is any guide, there may be trouble ahead for shares of Sanofi(NASDAQ:SNY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... Via Benzinga Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program October 07, 2021 Denali Therapeutics Inc (NASDAQ: DNLI) announced data from the Phase 1 trial evaluating DNL343, eIF2B activator, in 95 healthy volunteers. DNL343 was generally... Via Benzinga New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab October 06, 2021 FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in... Via FinancialNewsMedia Exposures COVID-19 Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates October 01, 2021 Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new... Via Benzinga The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs October 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results October 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... Via Benzinga Multiple Bits Of Bad News September 28, 2021 Republican debt ceiling brinkmanship boosted yields way over what stocks can pay, with info-tech the big loser. Via Talk Markets The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive September 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (... Via Benzinga Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know September 28, 2021 Sanofi SA (NASDAQ: SNY) is dropping plans for its mRNA-based COVID-19 vaccine because it believes it will be too late in reaching the market, STAT news reported. Sanofi... Via Benzinga Exposures COVID-19 Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism September 27, 2021 Sanofi SA (NASDAQ:SNY) shares traded higher by 0.4% on Mond... Via Benzinga Exposures COVID-19 Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 September 27, 2021 Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ: Via Benzinga Acceleron In Advanced $11B Buyout Talks: Bloomberg September 27, 2021 Frothy rumors about possible M&A discussions at Acceleron Pharma Inc (NASDAQ: XLRN) were capped with a Bloomberg report asserting that the Company is... Via Benzinga Pfizer Nabs Booster OK In U.S. — But How Long Will It Hold The Covid Lead? September 23, 2021 The FDA allowed the Pfizer-BioNTech Covid booster for some. But rivals are coming. Via Investor's Business Daily Exposures Product Safety < Previous 1 2 ... 23 24 25 26 27 28 29 30 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.